|
Profile Visibility  | | #142 in weekly profile views out of 12,333 lawyers in Boston, Massachusetts | | #13,998 in weekly profile views out of 968,565 total lawyers Overall |
|
|
| |
| Practice Areas | Intellectual Property Protection; Intellectual Property Litigation; Intellectual Property; Life Sciences; Business Law; Technology Law | | | Education | Harvard University, J.D., 1998, Harvard University, A.B., magna cum laude, 1988; University of California, Ph.D., 1993 | | | Admitted | 1998, Massachusetts; registered to practice before U.S. Patent and Trademark Office | |
| Born | 1967 | | | Biography | Intellectual Property Prosecution: complex patent portfolios, strategic landscape and freedom-to-operate reviews, patentability, infringement and inventorship opinions with specific expertise in small molecule, peptide, nucleic acid and antibody therapeutics, vaccines, diagnostic agents and instrumentation, magnetic resonance imaging, proteomics, genetic engineering, biopolymers and inks. Intellectual Property Litigation: assist in patent infringement cases within the life sciences and pharmaceutical industries. Technology Transactions & Licensing: assist clients in structure and negotiating license agreements, research collaborations, and strategic alliances based on technology and intellectual property assets. Investment Counsel: assist investors of all types in assessing the technology and intellectual property assets and risks for potential target investments. | | | ISLN | 913433100 | | | Transactions | Ongoing representation of several biotech and pharmaceutical companies with respect to IP protection and strategic partnerships. Advise major international company with regard to a large portfolio of molecular diagnostics products recently purchased from a top tier pharmaceutical. Advised major life sciences venture fund with respect to largest life sciences investment in Canadian company in 2006. Strategic representation of small clinical stage pharmaceutical company with regard to protection of their key product and management of their relationship with large pharmaceutical partner. IP counsel to major pharmaceutical company for several product portfolios in areas of small molecule therapeutics, biologics and vaccines. | |
|
|